In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Lukas BirštonasInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0009-0009-3544-3358 Sophie Tröger-GörlerDepartment of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), Jena, Germany.
Ingo BauerInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-3316-7769 Birte MertensInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Henrick SchwederDepartment of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), Jena, Germany.
Klaus FaserlProtein Core Facility, Institute of Medical Biochemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Axel A BrakhageDepartment of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), Jena, Germany.ORCID 0000-0002-8814-4193 Fabio GsallerInstitute of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-9257-8648 Funding
Austrian Science Fund P35951German Federal Ministry of Research Technology and Space 01KI2120A
6 · The paper itselfAbstract
Indexed as
AcetyltransferasesAspergillus fumigatusFungal ProteinsAntifungal AgentsBiosynthetic PathwaysGene Expression Regulation, FungalMultigene FamilyTranscription FactorsAcetyltransferasesAntifungal AgentsFungal ProteinsTranscription FactorsAspergillus fumigatusfumicycline (neosartoricin) biosynthetic clusterO-acetyltransferasesecondary metabolitestranscriptional regulation
Identifiers
PMID42695683
PMCPMC13688909
What OpenQuestion holds
Textmetadata
Read underepoch 390